qyscore

JSON twin: https://www.healthaidb.com/software/qyscore.json

Company Name

Qynapse

Product URL

https://qynapse.com/qyscore/

Company URL

https://qynapse.com/

Categories

Summary

QyScore is a cloud-based, FDA-cleared and CE-marked neuroimaging software that automatically segments, labels and provides volumetric quantification of brain structures to support diagnosis and monitoring of CNS diseases.

Description

QyScore (Qynapse) is a proprietary medical device software platform that performs fully automated, high-resolution MRI segmentation, volumetry and visualization for central nervous system structures and lesions. It generates automated patient reports, includes QC and preprocessing for clinical and clinical-trial use, and is deployed as a cloud-based solution designed for routine care, research and trial workflows. It is FDA-cleared (Class II) and CE-marked (Class IIa) with documented performance versus other tools and ISO/IEC/21 CFR and privacy compliances.

Api Available

unknown

Certifications

Company Founding

2015

Company Offices

Compliance

Customers

Data Residency

Global cloud hosting with regional offices (France, USA, Canada); HDS-certified hosting option (France) available

Data Standards

Deployment Model

Features

Id

P2024

Integration Partners

Integrations

Languages Supported

Last Updated

2025-09-07

License

Commercial proprietary

Links

Market Segment

Optional Modules

Os Platforms

Pricing Details

Contact vendor for pricing, deployment and trial/demo information.

Pricing Model

enterprise_quote

Privacy Features

Ratings

Regions Available

Release Year

2020

Security Features

Specialties

Support Channels

System Requirements

Modern web browser; DICOM connectivity to PACS/DICOM server; internet access for cloud service

Target Users

Training Options

Type

product

User Reviews

Version

1.0

Canonical JSON

{
  "company_name": "Qynapse",
  "company_url": "https://qynapse.com/",
  "company_offices": [
    "France",
    "United States",
    "Canada"
  ],
  "company_founding": "2015",
  "product_url": "https://qynapse.com/qyscore/",
  "categories": [
    "clinical",
    "diagnostic",
    "imaging",
    "neuroimaging",
    "decision support",
    "research",
    "clinical trials"
  ],
  "market_segment": [
    "enterprise",
    "research",
    "healthcare providers",
    "pharma"
  ],
  "links": [
    "https://qynapse.com/qyscore/",
    "https://qynapse.com/",
    "https://qynapse.com/company/",
    "https://manuals.qynapse.com/",
    "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K192531",
    "https://healthairegister.com/products/qynapse-qyscore",
    "https://www.prnewswire.com/news-releases/qynapse-receives-fda-clearance-for-qyscore-a-novel-imaging-software-for-central-nervous-system-diseases-300997612.html",
    "https://www.biospace.com/b-qynapse-b-receives-ce-mark-for-qyscore-cloud-based-solution-for-automatic-extraction-quantification-and-comparison-to-normative-dataset-of-imagi/"
  ],
  "summary": "QyScore is a cloud-based, FDA-cleared and CE-marked neuroimaging software that automatically segments, labels and provides volumetric quantification of brain structures to support diagnosis and monitoring of CNS diseases.",
  "description": "QyScore (Qynapse) is a proprietary medical device software platform that performs fully automated, high-resolution MRI segmentation, volumetry and visualization for central nervous system structures and lesions. It generates automated patient reports, includes QC and preprocessing for clinical and clinical-trial use, and is deployed as a cloud-based solution designed for routine care, research and trial workflows. It is FDA-cleared (Class II) and CE-marked (Class IIa) with documented performance versus other tools and ISO/IEC/21 CFR and privacy compliances.",
  "target_users": [
    "radiologists",
    "neurologists",
    "clinicians",
    "researchers",
    "pharma clinical trial teams",
    "payers",
    "imaging scientists",
    "neuroimaging-trained personnel",
    "clinical site technicians",
    "IT/admins"
  ],
  "specialties": [
    "Alzheimer's disease / dementia",
    "multiple sclerosis",
    "Parkinson's disease / movement disorders",
    "neurodegeneration",
    "neuroinflammation",
    "ischemic stroke (in development)",
    "Huntington's disease (in development)",
    "epilepsy (in development)",
    "traumatic brain injury (in development)",
    "psychiatry: schizophrenia, depression (in development)"
  ],
  "regions_available": [
    "United States",
    "European Union",
    "France",
    "Canada",
    "Global (select markets)"
  ],
  "languages_supported": [
    "English",
    "French"
  ],
  "pricing_model": "enterprise_quote",
  "pricing_details": "Contact vendor for pricing, deployment and trial/demo information.",
  "license": "Commercial proprietary",
  "deployment_model": [
    "cloud (SaaS)",
    "web-based"
  ],
  "os_platforms": [
    "Web (modern browser)"
  ],
  "features": [
    "automated volumetric segmentation of brain structures",
    "quantification of whole brain, lobes, cerebellum, WM/GM, WMH",
    "automated patient report generation (downloadable)",
    "3D visualization/renderer of segmentations",
    "longitudinal comparison and trend graphs",
    "pre-processing and automated quality control",
    "volume percentile comparison to reference dataset",
    "ROI opacity and window/level controls",
    "CSV report export",
    "user feedback / QC annotation workflow"
  ],
  "optional_modules": [
    "clinical-trial workflow / batch processing",
    "longitudinal analysis module"
  ],
  "integrations": [
    "PACS / DICOM server",
    "on-prem DICOM archive",
    "site-specific HL7 interface (for IT integration)"
  ],
  "data_standards": [
    "DICOM",
    "HL7 v2"
  ],
  "api_available": "unknown",
  "system_requirements": "Modern web browser; DICOM connectivity to PACS/DICOM server; internet access for cloud service",
  "compliance": [
    "HIPAA compliant",
    "GDPR compliant",
    "21 C.F.R. Part 11 compliant"
  ],
  "certifications": [
    "FDA cleared (510(k))",
    "CE marked (CE2797)",
    "ISO 13485",
    "ISO/IEC 27001",
    "HDS (France health data hosting)"
  ],
  "security_features": [
    "ISO/IEC 27001-aligned security controls",
    "audit logging (user actions and reports)",
    "encrypted data transfer (TLS)"
  ],
  "privacy_features": [
    "HIPAA compliance / BAA available",
    "GDPR compliance"
  ],
  "data_residency": "Global cloud hosting with regional offices (France, USA, Canada); HDS-certified hosting option (France) available",
  "customers": [
    "Pacific Brain Health Center / Pacific Neuroscience Institute",
    "Pitié-Salpêtrière Hospital / Sorbonne University (research collaborators / advisors)",
    "Tower Imaging Medical Group",
    "UnitedHealthcare Specialty Benefits (represented by former CEO advisor)",
    "University of Miami (research collaboration)"
  ],
  "user_reviews": [],
  "ratings": [
    "FDA 510(k) clearance for QyScore® (FDA 2020)",
    "CE marked (CE2797)",
    "ISO 13485 certified",
    "ISO/IEC 27001 certified",
    "HIPAA compliant"
  ],
  "support_channels": [
    "email",
    "documentation",
    "contact form"
  ],
  "training_options": [
    "documentation (user manuals)",
    "webinars",
    "live_online (demos)"
  ],
  "release_year": "2020",
  "integration_partners": [
    "Calyx",
    "Blackford Analysis",
    "University of Miami (research partner)"
  ],
  "id": "P2024",
  "slug": "qyscore",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-09-07",
  "links_json": {
    "self": "https://www.healthaidb.com/software/qyscore.json"
  }
}